There were 3 control groups: patients with RA starting methotrexate therapy (no anti-TNF-alpha therapy; total N ~6,000); patients with RA starting nonbiologic combination therapy (total N ~1,800 ...

REMICADE was the first anti-TNF-alpha treatment approved ... And in April 2003, it became the first TNF-alpha inhibitor approved for maintenance therapy of fistulising Crohn’s disease.

Recently, a team of researchers in the United Kingdom set out to test the effectiveness of anti-TNF-alpha therapy on a small sample of patients with very early, poor-prognosis, previously ...

and anti-tumor necrosis factor-alpha (anti-TNF-α) agents are considered the treatments of choice. For patients with inadequate responses to DMARD therapy, one recommended therapeutic alternative ...

early anti-tumor necrosis factor-alpha (anti-TNFα) therapy is beneficial in preventing the development of perianal fistula complications (PFCs), according to a study published online Dec. 12 in Gut.

Previous research has suggested a genetic and functional link between IBD and PD, however evidence regarding this association has been limited. Patients with inflammatory bowel disease (IBD ...

Given the expense and risk profiles of anti-TNF agents, measures that can identify ... have greater short-term symptomatic response to therapy.

Anti-TNF-α therapy for CRS following COVID-19 infection ... clones have been made available by ACROBiosystems: Human TNF-alpha Protein, His Tag (active trimer) (MALS confirmed) is the immunogen ...

and offers Oculis the opportunity to address unmet medical needs of patients with potentially the first topical anti-TNF alpha therapy for ophthalmic indications. Oculis plans to develop OCS-02 in ...

Additionally, maintenance of anti-TNF alpha during the final trimester of ... children born to mothers with IBD who are on anti-TNF therapy are that vaccines should be administered as with any ...